Phase 4
N=68
The Use of Antibiotic Sinonasal Rinse After Sinus Surgery
Chronic Rhinosinusitis
Bottom Line
View on ClinicalTrials.gov: NCT02218307 ↗Enrolled (actual)
68
Serious AEs
0.0%
Results posted
Mar 2017
Primary outcome: Primary: Quality of Life in Chronic Rhinosinusitis Patients — 23; 21 Units on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 4
- Interventions
- Mupirocin (Drug); Placebo (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Miami
- Primary completion
- Jun 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Quality of Life in Chronic Rhinosinusitis Patients |
24.8; 26.4 | — |
| SECONDARY Quality of Life in Chronic Rhinosinusitis Patients |
24.8; 26.4 | — |
Summary
Double blind placebo controlled trial to evaluate whether the routine use of nasal irrigation with mupirocin is more effective than saline irrigations alone in reducing symptoms of chronic rhinosinusitis in the early postoperative period.
Eligibility Criteria
Inclusion Criteria
- Chronic Rhinosinusitis
- Undergoing endoscopic sinus surgery
Exclusion Criteria
- Age under 18
- Documented adverse reaction to mupirocin
Data sourced from ClinicalTrials.gov (NCT02218307). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.